Jennifer Doudna
Jennifer Doudna and Emmanuelle Charpentier
Doudna and Charpentier’s 2012 work established CRISPR-Cas9 as the first programmable, RNA-guided DNA cleavage system. It relies on Cas9 protein and a synthetic guide RNA chimera. It works in vitro. It does not demonstrate editing in living organisms or repair outcomes. It is the origin of all subsequent CRISPR applications — not a refinement, but the first functional design.